Canlyniadau Chwilio - Milind Javle

Mireinio'r Canlyniadau
  1. 1
    Molecular profiling of biliary tract cancer: a target rich disease

    Molecular profiling of biliary tract cancer: a target rich disease gan Apurva Jain, Milind Javle

    Cyhoeddwyd 2016
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    The role of PARP in DNA repair and its therapeutic exploitation

    The role of PARP in DNA repair and its therapeutic exploitation gan Milind Javle, Nicola J. Curtin

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma

    Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma gan Yun Shin Chun, Milind Javle

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer

    Ramucirumab: Successfully Targeting Angiogenesis in Gastric Cancer gan Milind Javle, Elizabeth Smyth, Ian Chau

    Cyhoeddwyd 2014
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Systemic therapy for gallbladder cancer

    Systemic therapy for gallbladder cancer gan Milind Javle, Haitao Zhao, Ghassan K. Abou‐Alfa

    Cyhoeddwyd 2019
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Nuclear or cytoplasmic expression of survivin: What is the significance?

    Nuclear or cytoplasmic expression of survivin: What is the significance? gan Fengzhi Li, Jie Yang, Nithya Ramnath, Milind Javle, Dongfeng Tan

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of<i>FGFR</i>-Aberrant Tumors

    Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of<i>FGFR</i>-Aberrant Tumors gan Milind Javle, Gentry Teng King, Kristen Spencer, Mitesh J. Borad

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Single Nucleotide Polymorphisms of Gemcitabine Metabolic Genes and Pancreatic Cancer Survival and Drug Toxicity

    Single Nucleotide Polymorphisms of Gemcitabine Metabolic Genes and Pancreatic Cancer Survival and Drug Toxicity gan Taro Okazaki, Milind Javle, Motofumi Tanaka, James L. Abbruzzese, Donghui Li

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice

    FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice gan Anuhya Kommalapati, Sri Harsha Tella, Mitesh J. Borad, Milind Javle, Amit Mahipal

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer

    Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer gan Motofumi Tanaka, Milind Javle, Xiaoqun Dong, Cathy Eng, James L. Abbruzzese, Donghui Li

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer

    Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer gan Milind Javle, Yanan Li, Dongfeng Tan, Xiaoqun Dong, Ping Chang, Siddhartha Kar, Donghui Li

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    The inflammatory inception of gallbladder cancer

    The inflammatory inception of gallbladder cancer gan Jaime A. Espinoza, Carolina Bizama, Patricia García, Catterina Ferreccio, Milind Javle, Juan Francisco Miquel, Jill Koshiol, Juan Carlos Roa

    Cyhoeddwyd 2016
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference

    Liver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference gan Gonzalo Sapisochín, Milind Javle, Jan Lerut, Masayuki Ohtsuka, R. Mark Ghobrial, Taizo Hibi, Nancy Man Kwan, Julie K. Heimbach

    Cyhoeddwyd 2020
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Gallbladder Cancer: expert consensus statement

    Gallbladder Cancer: expert consensus statement gan Thomas A. Aloia, Nicolás Jarufe, Milind Javle, Shishir K. Maithel, Juan Carlos Roa, Volkan Adsay, Felipe José Fernández Coimbra, William R. Jarnagin

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma

    Randomized, phase I/II study of gemcitabine plus IGF-1R antagonist (MK-0646) versus gemcitabine plus erlotinib with and without MK-0646 for advanced pancreatic adenocarcinoma gan Reham Abdel‐Wahab, Gauri R. Varadhachary, Priya Bhosale, Xuemei Wang, David R. Fogelman, Rachna T. Shroff, Michael J. Overman, Robert A. Wolff, Milind Javle

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer

    Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer gan Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, Tove Buhl, Rune Smaaland, Herish Garresori, Milind Javle, Nils Glenjen, B.K. Abelseth, Bjørnar Gilje, Oddmund Nordgård

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Next‐generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance

    Next‐generation sequencing survey of biliary tract cancer reveals the association between tumor somatic variants and chemotherapy resistance gan Daniel H. Ahn, Milind Javle, Chul Ahn, Apurva Jain, Sameh Mikhail, Anne M. Noonan, Christina Wu, Rachna T. Shroff, James L. Chen, Tanios Bekaii‐Saab

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma

    Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma gan Nawapol Kunkeaw, Sung Ho Jeon, K Lee, Betty H. Johnson, S. Tanasanvimon, Milind Javle, Chawalit Pairojkul, Yaovalux Chamgramol, Wipaporn Wongfieng, Bin Gong, Chanvit Leelayuwat, Y S Lee

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study

    Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater: A single‐center, open‐label, phase 2 study... gan Pat Gulhati, Kanwal Raghav, Rachna T. Shroff, Gauri R. Varadhachary, Scott Kopetz, Milind Javle, Wei Qiao, Huamin Wang, Jeffrey S. Morris, Robert A. Wolff, Michael J. Overman

    Cyhoeddwyd 2016
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants

    Olaparib Monotherapy for Previously Treated Pancreatic Cancer With DNA Damage Repair Genetic Alterations Other Than Germline <i>BRCA</i> Variants gan Milind Javle, Einat Shacham‐Shmueli, Lianchun Xiao, Gauri Varadhachary, Naama Halpern, David R. Fogelman, Ben Boursi, Syeda Uruba, Ofer Margalit, Robert A. Wolff, Talia Golan

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: